MEDITATION. MASSAGE. ENDORPHINS. THE SMELL OF VANILLA. THE COOL OF JAZZ. THE TRANSCENDENCE OF OPERA. THE TASTE OF CHOCOLATE AND FINE WINE.
Delightful Moments such as these are part of all human experience: the small, but powerful, separations from the daily humdrum when we feel stronger, calmer, more joyful, more in control, more distant from pain and anxiety.
Now, emerging science and technology has the potential to deliver these experiences. Science can help individuals be a bit happier, which can lead to greater health. Or a little healthier, which can lead to greater potential for happiness. It is a new, transformative cycle of human experience.
This new science of health and happiness ranges from transforming the human organism (genetics, bioscience), to creating new forms of human chemistry (the microbiome), to reading, understanding or altering our minds (neuroscience), to expanding human experience (virtual and augmented reality), and even to altering what we eat and drink (next generation food) and how we interact with one another (emergent community).
By investing in the emerging science of happiness, Joyance Partners is the first venture fund focused on individual health experience, not process.
Joyance focuses on consumer goods derived from deep science with high emotional content.
Managing Partner Mike Edelhart talks with Dalton Combs, CEO of Boundless Mind, a company that uses neuroscience and AI to personalize your app for every user.
Health and happiness science is one of the most profound investment opportunities in decades.
Managing Partner Mike Edelhart talks with Lindsay Jurist-Rodner, CEO of Wellthy, a company that connects families with their own private care coordinator.
Lark Health CEO Julia Hu explains what it will take for a digital health revolution to occur.
Managing Partner Mike Edelhart talks with Tyler Shultz, CEO of of Flux Biosciences, a company that uses innovative tech to perform point-of-care in vitro medical diagnostics.